Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians | ||
By: GlobeNewswire - 14 Mar 2024 | Back to overview list |
|
Follows successful evaluation by Omaha Pain Physicians’ founder and medical director, Dr. Matthew Stottle, reporting 100% success ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables to Omaha Pain Physicians, a comprehensive medical pain management center in Omaha, NE. Omaha Pain Physicians is focused on treating patients with acute and chronic pain. Adoption of the technology by this clinic follows a successful evaluation process by its founder and medical director, Dr. Matthew Stottle, an interventional pain medicine physician, who is board-certified by the American Board of Anesthesiology in both anesthesiology and pain medicine. Dr. Matthew Stottle completed 10 cases using the CompuFlo Epidural system at Omaha Pain Physicians, in which he reported 100% success. The evaluation included Epidural Steroid Injection (ESI) procedures within the lumbar, thoracic and cervical thoracic junction of the spine. Dr. Matthew Stottle stated, “CompuFlo offers significant safety enhancements when performing an ESI procedure. In turn, this provides a safer method to deliver the medication to the treatment area.” Arjan Haverhals, CEO and president of Milestone Scientific, stated, “We are pleased to witness the adoption of our technology by an additional pain management clinic. Similar to preceding practices, Omaha Pain Physicians conducted a successful evaluation period, reinforcing the ongoing success and safety of the CompuFlo system, which we believe will help advance our efforts on the reimbursement front. We appreciate the support of Dr. Stottle, which illustrates his commitment to incorporating the latest technologies to ensure the best patient outcomes.” About Milestone Scientific Inc. Safe Harbor Statement Contact: David Waldman or Natalya Rudman
|
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |